Michael Lanuti
Director, Thoracic Oncology, Division of Thoracic Surgery Associate Professor Harvard Medical School · Mass General Brigham
Credentials: · · · ·
History
- Present
- Present
Mass General Brigham · Harvard School of Public Health
- 2003–2004
- 1994–2000
- 1986–1990
Research
Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors
Science Translational Medicine · 2011 · 2,891 citations
Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2022 · 1,255 citations
Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2017 · 1,060 citations
- DM
44 papers
- CW
43 papers
- HG
34 papers
- AM
33 papers
- MM
31 papers
26 papers
24 papers
24 papers
Grants
- 2016–2020
PET Imaging of Pulmonary Fibrosis
National Heart, Lung, and Blood Institute · R01
PI · $2.3M · Massachusetts General Hospital
- 2009–2011
Prodrug Enzyme Therapy of Pancreatic Cancer Mediated by Oncolytic HSV Vector
National Cancer Institute · R03
Contact PI · $159.1K · Massachusetts General Hospital
Clinical trials
- 2020–2027
Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury
Principal investigator · Recruiting · Phase 2
Massachusetts General Hospital
- 2018–2019
Neoadjuvant Chemotherapy or Chemoradiotherapy in Resectable Oesophageal Carcinoma（NewEC Study）
Principal investigator · Completed
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- 2022–2026
Site PI · Unknown
Lung Cancer Mutation Consortium